ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer

被引:4
作者
Coleman, R. L. [1 ]
Fujiwara, K. [2 ]
Sehouli, J. [3 ]
Salutari, V. [4 ]
Zola, P. [5 ]
Madry, R. [6 ,7 ]
Korach, J. [8 ]
Pautier, P. [9 ]
Cibula, D. [10 ,11 ]
Lheureux, S. [12 ]
Hasegawa, K. [2 ]
Kim, B. G. [13 ]
Lai, C. H. [14 ,15 ]
Gonzalez-Martinez, A. [16 ,17 ]
Liu, Q. [18 ]
Keefe, S. [18 ]
Puglisi, M. [18 ]
Topuz, S. [19 ]
Monk, B. J. [20 ]
Arend, R. C. [21 ]
O'Malley, D. M. [22 ]
Vergote, I. [23 ,24 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Saitama Med Univ, Int Med Ctr, Hidaka, Japan
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Policlin Univ Agostino Gemelli, Rome, Italy
[5] Univ Turin, Turin, Italy
[6] Uniwersytet Med K Marcinkowskiego Poznaniu, Poznan, Poland
[7] Szpital Klin Przemienienia, Poznan, Poland
[8] Josef Buchmann Gynecol & Matern Ctr, Ramat Gan, Israel
[9] Inst Gustave Roussy, Villejuif, France
[10] Charles Univ Prague, Prague, Czech Republic
[11] Gen Fac Hosp, Prague, Czech Republic
[12] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[13] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[14] Chang Gung Mem Hosp, Taoyuan, Taiwan
[15] Chang Gung Univ, Taoyuan, Taiwan
[16] GEICO, Pamplona, Spain
[17] Clin Univ Navarra, Pamplona, Spain
[18] Merck & Co Inc, Kenilworth, NJ USA
[19] Istanbul Med Fac Hosp, Istanbul, Turkey
[20] Biltmore Canc Ctr, Phoenix, AZ USA
[21] Univ Alabama Birmingham, Birmingham, AL USA
[22] Ohio State Univ, Columbus Canc Council, Hilliard, OH USA
[23] Belgian Gynecol Oncol Grp BGOG, Leuven, Belgium
[24] Univ Leuven, Leuven Canc Inst, Leuven, Belgium
关键词
D O I
10.1016/j.ygyno.2020.05.070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
182
引用
收藏
页码:89 / 90
页数:2
相关论文
empty
未找到相关数据